Global MRE Adoption Resoundant has installed MRE upgrades on MRI systems from major manufacturers (Philips, GE, Siemens) across over 800 locations worldwide, indicating a broad potential install base for expansion and cross-selling of upgrades, service contracts, and training.

FDA Cleared Add-On MRE is FDA-cleared as an MR add-on technology, simplifying regulatory hurdles for procurement and enabling faster negotiation with hospitals and imaging centers that already use MRI platforms.

Clinical Expansion Potential Current clinical use focuses on liver fibrosis with strong research promise in brain, muscle, breast, kidney, spine, heart, suggesting opportunities to position MRE as a multi-application diagnostic enhancement in radiology protocols.

Strategic Partnerships Past collaborations with United Imaging Group and notable leadership additions (e.g., COO appointment, board member) imply a readiness to pursue new channel partnerships, co-marketing, and joint sales initiatives to accelerate market reach.

Mid-Sized Growth With 11-50 employees and reported revenue in the low-to-mid single digits, there is room to scale through channel sales, focused clinical ambassadors, and customer success programs targeted at imaging centers and hospitals upgrading MRI capabilities.